Published in AIDS Care on June 01, 2002
Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity. Antimicrob Agents Chemother (2005) 7.42
Asymmetric allylboration of acyl imines catalyzed by chiral diols. J Am Chem Soc (2007) 1.60
Medication adherence and its determinants among patients on concomitant tuberculosis and antiretroviral therapy in South west ethiopia. N Am J Med Sci (2012) 1.47
Barriers and facilitators to medication adherence in a southern minority population with HIV disease. J Assoc Nurses AIDS Care (2008) 1.44
Socioeconomic status (SES) as a determinant of adherence to treatment in HIV infected patients: a systematic review of the literature. Retrovirology (2008) 1.30
A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV+ crack cocaine users. Drug Alcohol Depend (2011) 1.19
Livelihood security and adherence to antiretroviral therapy in low and middle income settings: a systematic review. PLoS One (2011) 1.09
Reduction of CCR5 with low-dose rapamycin enhances the antiviral activity of vicriviroc against both sensitive and drug-resistant HIV-1. Proc Natl Acad Sci U S A (2008) 1.09
Baseline predictors of ninety percent or higher antiretroviral therapy adherence in a diverse urban sample: the role of patient autonomy and fatalistic religious beliefs. AIDS Patient Care STDS (2011) 1.05
Adherence to antiretroviral therapy in a context of universal access, in Rio de Janeiro, Brazil. AIDS Care (2007) 1.04
Linkage, engagement, and viral suppression rates among HIV-infected persons receiving care at medical case management programs in Washington, DC. J Acquir Immune Defic Syndr (2013) 0.99
Determinants of optimal adherence over time to antiretroviral therapy amongst HIV positive adults in South Africa: a longitudinal study. AIDS Behav (2011) 0.97
Pilot testing of an HIV medication adherence intervention in a public clinic in the Deep South. J Am Acad Nurse Pract (2012) 0.95
Utility of an interactive voice response system to assess antiretroviral pharmacotherapy adherence among substance users living with HIV/AIDS in the rural South. AIDS Patient Care STDS (2013) 0.90
Factors Supporting and Inhibiting Adherence to HIV Medication Regimen in Women: A Qualitative Analysis of Patient Interviews. Open AIDS J (2015) 0.88
Treatment retention and care transitions during and after the scale-up of HIV care and treatment in Northern Tanzania. AIDS Care (2014) 0.87
Individual and contextual factors of influence on adherence to antiretrovirals among people attending public clinics in Rio de Janeiro, Brazil. BMC Public Health (2013) 0.86
Development and validation of a measure for intention to adhere to HIV treatment. AIDS Patient Care STDS (2012) 0.83
Pharmacotherapy of HIV-1 Infection: Focus on CCR5 Antagonist Maraviroc. Clin Med Ther (2009) 0.83
Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention. AIDS Behav (2015) 0.82
Rates of inappropriate antiretroviral prescription among injection drug users. Harm Reduct J (2007) 0.81
Missed Doses and Missed Appointments: Adherence to ART among Adult Patients in Uganda. ISRN AIDS (2013) 0.80
Life Lessons from Women with HIV: Mutuality, Self-Awareness, and Self-Efficacy. AIDS Patient Care STDS (2016) 0.78
Interactive effects of neurocognitive impairment and substance use on antiretroviral non-adherence in HIV disease. Arch Clin Neuropsychol (2015) 0.78
A Dyadic Behavioral Intervention to Optimize Same Sex Male Couples' Engagement Across the HIV Care Continuum: Development of and Protocol for an Innovative Couples-based Approach (Partner Steps). JMIR Res Protoc (2016) 0.77
Using the multiphase optimization strategy (MOST) to optimize an HIV care continuum intervention for vulnerable populations: a study protocol. BMC Public Health (2017) 0.75
Illness Representations of HIV Positive Patients Are Associated with Virologic Success. Front Psychol (2016) 0.75
Do we prescribe what patients prefer? Pilot study to assess patient preferences for medication regimen characteristics. Patient Prefer Adherence (2012) 0.75
Antiretroviral drug diversion links social vulnerability to poor medication adherence in substance abusing populations. AIDS Behav (2015) 0.75
Project Stronger Together: Protocol to Test a Dyadic Intervention to Improve Engagement in HIV Care Among Sero-Discordant Male Couples in Three US Cities. JMIR Res Protoc (2017) 0.75
Phosphatidylethanol (PEth) as a Biomarker of Alcohol Consumption in HIV-Infected Young Russian Women: Comparison to Self-Report Assessments of Alcohol Use. AIDS Behav (2017) 0.75
IMPLEMENTATION OF A SCHOOL-BASED HIV PREVENTION CURRICULUM FOLLOWING NATIONAL DISSEMINATION IN NYANZA PROVINCE, KENYA. East Afr Med J (2014) 0.75
The sheltered homeless and medications: implications for health care. J Am Acad Nurse Pract (1996) 0.75